https://doctransparency.com/doctor/tx/plano/mark-valente-1194930453
Not Medicare Enrolled

Dr. Mark Valente, D.O.

Orthopaedic Surgery of the Spine Physician · Plano, TX
Mixed engagement
6200 PRESTON RD STE 300, Plano, TX 75024
9727070005
In practice since 2007 (18 years)
NPI: 1194930453 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Valente from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valente? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Valente

Dr. Mark Valente is an orthopaedic surgery of the spine physician in Plano, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Valente received a total of $350,991 from 26 pharmaceutical and/or device companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in orthopaedic surgery of the spine physician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Valente is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $350,991 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$350,991
Total received (2018-2024)
Avg $50,142/year across 7 years
Top 14% in TX for orthopaedic surgery of the spine physician
26
Companies
200
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$246,816 (70.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$95,759 (27.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,981 (1.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,435 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$64,198
2023
$68,602
2022
$53,236
2021
$43,282
2020
$64,574
2019
$56,297
2018
$801

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Evolution Spine, LLC
$342,575
Allergan, Inc.
$3,329
Merz North America, Inc.
$1,243
ABBVIE INC.
$1,016
AbbVie Inc.
$636
Medtronic, Inc.
$366
Boston Scientific Corporation
$313
Relievant Medsystems, Inc.
$298
4WEB, Inc.
$257
Orthofix Medical, Inc.
$192
Allergan Inc.
$177
DePuy Synthes Sales Inc.
$170
Horizon Therapeutics plc
$95
Globus Medical, Inc.
$77
Spineology Inc.
$46
Abbott Laboratories
$29
Stryker Corporation
$24
Intrinsic Therapeutics
$23
SI-BONE, Inc.
$19
Trevena, Inc.
$19
Radius Health, Inc.
$17
Choice Spine, LLC
$17
Kowa Pharmaceuticals America, Inc.
$15
Ethicon US, LLC
$13
Wenzel Spine, Inc.
$12
Horizon Pharma plc
$11
Top 3 companies account for 98.9% of total payments
Associated products mentioned in payments ›
BARRICAID ACD (ANNULAR CLOSURE DEVICE) · BLACKHAWK CERVICAL SPACER SYSTEM · BOTOX · BOTOX COSMETIC · CAPRI CORPECTOMY CAGE SYSTEM · DUEXIS · Emerge Anterior Cervical Plate System · FIBERGRAFT · INTELLIS · INTELLIS ADAPTIVESTIM · Integrated ALIF System · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · LUX-Dx Insertable Cardiac Monitor · MAZOR X SYSTEM · Neuromodulation Dspsbls and Accs · OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM · Olinvyk · OptiMesh Interbody Fusion System · PENNSAID · RAYOS · RISE-L · RISE-L . RISE-L A/L · SEGLENTIS · SPECTRA WAVEWRITER · SPINE TRUSS SYSTEM · STEALTHSTATION S8 PLATFORM · STRATAFIX · SYMPHONY · Trinity ELITE · Tymlos · VIPER · VariLift-LX · Whistler Modular Screw System and Lumbar and Cervical Plates and Cages · Whistler Pedicle Screw System · XEOMIN · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Looking for a orthopaedic surgery of the spine physician in Plano?
Compare orthopaedic surgery of the spine physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse orthopaedic surgery of the spine physicians nearby

Geographic Context

Orthopaedic Surgery of the Spine Physicians within 10 mi
48
Per 100K population
4.3
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Valente is a orthopaedic surgery of the spine physician, and high industry engagement (mixed engagement, top 14%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Valente receive payments from pharmaceutical companies?
Yes. Dr. Valente received a total of $350,991 from 26 companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Valente) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →